Sign inJoin waitlistJoin the waitlist

Martin Gutierrez

Physician · Regional Cancer Care Associates LLC

Credentials: · · · · ·

History

Regional Cancer Care Associates LLC
Present

Center for Cancer Research
1997–2000
National Institutes of Health
Internal Medicine
Boston University Medical Center
1991–1994
PONTIFICIA UNIV, FAC DE MED, JAVERIANA, BOGOTA, COLOMBIA
1987–1991

Research

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma
New England Journal of Medicine · 2015 · 2,937 citations
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
Journal of Clinical Oncology · 2016 · 869 citations
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers
Journal of Clinical Oncology · 2019 · 484 citations

Shivaani Kummar
25 papers
James Doroshow
16 papers
AC
Alice Chen
8 papers
Elaine Jaffe
8 papers
GG
Giuseppe Giaccone
8 papers
William Figg
8 papers
Wyndham Wilson
8 papers
Andre Goy
5 papers
Andrew Ip
5 papers
Ani Balmanoukian
5 papers
DS
David Spigel
5 papers
DR
Drew Rasco
5 papers

Clinical trials

Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy
Principal investigator · Terminated · Phase 2
Hackensack Meridian Health
2023–2026
YL-13027 in Patients With Advanced Solid Tumors
Principal investigator · Unknown · Phase 1
Shanghai YingLi Pharmaceutical Co. Ltd.
2022–2023
Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air
Principal investigator · Unknown
Rauscher, Gregory E., M.D. PA
2013
Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma
Site PI · Not yet recruiting · Phase 2
Rapa Therapeutics LLC
2027–2029